Kukje Pharma Co Ltd Asset Resilience Ratio

Latest as of September 2025: 0.02%

Kukje Pharma Co Ltd asset resilience ratio. Kukje Pharma Co Ltd (002720) has an Asset Resilience Ratio of 0.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Kukje Pharma Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩43.23 Million

≈ $29.30K USD Cash + Short-term Investments

Total Assets

₩180.12 Billion

≈ $122.06 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Kukje Pharma Co Ltd (2011–2024)

Asset resilience ratio of Kukje Pharma Co Ltd from 2011 to 2024. This chart shows how Kukje Pharma Co Ltd's Asset Resilience Ratio has changed over time. Read 002720 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Kukje Pharma Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Kukje Pharma Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩43.23 Million	0.02%
Total Liquid Assets	₩43.23 Million	0.02%

Asset Resilience Insights

Limited Liquidity: Kukje Pharma Co Ltd maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Kukje Pharma Co Ltd Industry Peers by Asset Resilience Ratio

Compare Kukje Pharma Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Kukje Pharma Co Ltd Asset Resilience Ratio by Year (2011–2024)

Kukje Pharma Co Ltd asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for Kukje Pharma Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.05%	₩76.49 Million ≈ $51.84K	₩165.55 Billion ≈ $112.19 Million	+0.02pp
2023-12-31	0.03%	₩42.29 Million ≈ $28.66K	₩163.26 Billion ≈ $110.64 Million	+0.01pp
2022-12-31	0.01%	₩20.18 Million ≈ $13.67K	₩136.59 Billion ≈ $92.57 Million	-0.01pp
2021-12-31	0.03%	₩36.91 Million ≈ $25.01K	₩139.78 Billion ≈ $94.73 Million	-0.15pp
2020-12-31	0.18%	₩260.42 Million ≈ $176.49K	₩145.63 Billion ≈ $98.69 Million	-2.00pp
2019-12-31	2.18%	₩2.93 Billion ≈ $1.99 Million	₩134.59 Billion ≈ $91.21 Million	-0.69pp
2018-12-31	2.87%	₩3.62 Billion ≈ $2.46 Million	₩126.23 Billion ≈ $85.55 Million	+2.14pp
2017-12-31	0.73%	₩962.34 Million ≈ $652.16K	₩131.65 Billion ≈ $89.21 Million	+0.49pp
2016-12-31	0.24%	₩307.92 Million ≈ $208.67K	₩129.46 Billion ≈ $87.73 Million	+0.01pp
2015-12-31	0.23%	₩317.85 Million ≈ $215.41K	₩136.64 Billion ≈ $92.60 Million	+0.16pp
2014-12-31	0.07%	₩86.58 Million ≈ $58.67K	₩117.51 Billion ≈ $79.63 Million	-1.28pp
2013-12-31	1.36%	₩1.59 Billion ≈ $1.08 Million	₩117.43 Billion ≈ $79.58 Million	+1.29pp
2012-12-31	0.07%	₩75.16 Million ≈ $50.93K	₩114.92 Billion ≈ $77.88 Million	+0.06pp
2011-12-31	0.01%	₩10.58 Million ≈ $7.17K	₩141.61 Billion ≈ $95.97 Million	--

pp = percentage points

About Kukje Pharma Co Ltd

KO:002720 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$46.37 Million

₩68.42 Billion KRW

Market Cap Rank

#21989 Global

#1353 in Korea

Share Price

₩3360.00

Change (1 day)

-2.04%

52-Week Range

₩3045.00 - ₩5230.00

All Time High

₩12612.03